News
Using eXoZymes' AI-driven platform, a new and proprietary approach to biomanufacturing of NCT - with all the scale-up advantages of an exozyme biosolution - has been developed: Progressing from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results